Barclays PLC Pro Phase Labs, Inc. Transaction History

Barclays PLC

$353 Billion
Q1 2025

A detailed history of Barclays PLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Barclays PLC holds 12,572 shares of PRPH stock, worth $3,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,572

Holding current value

$3,897

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.24 - $0.88 $3,017 - $11,063	12,572 New	12,572 $5,000
Q2 2024 Aug 14, 2024	BUY	$4.18 - $7.35 $49,186 - $86,487	11,767 New	11,767 $49,000
Q2 2023 Aug 03, 2023	BUY	$7.15 - $9.78 $1,058 - $1,447	148 New	148 $1,000
Q2 2021 Aug 13, 2021	SELL	$4.61 - $6.83 $2,291 - $3,394	-497 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$6.19 - $16.0 $3,076 - $7,952	497 New	497 $4,000
Q3 2020 Nov 12, 2020	SELL	$1.4 - $3.87 $26 - $73	-19 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.2 - $1.99 $22 - $37	19 New	19 $0
Q2 2019 Aug 14, 2019	SELL	$2.1 - $3.07 $134 - $196	-64 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.7 - $3.65 $172 - $233	64 New	64 $0
Q2 2018 Aug 14, 2018	SELL	$2.84 - $5.41 $14 - $27	-5 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.24 - $3.21 $11 - $16	5 New	5 $0

Others Institutions Holding PRPH

# of Institutions

Shares Held

4.95M

Call Options Held

Put Options Held

Wexford Capital LP Greenwich, CT

1.53M
Shares

$472,939
0.18% of portfolio
Vanguard Group Inc Valley Forge, PA

408K
Shares

$126,562
0.0% of portfolio
Four World Capital Management LLC New York, NY

377K
Shares

$116,738
0.1% of portfolio
Quinn Opportunity Partners LLC Charlottesville, VA

318K
Shares

$98,619
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

300K
Shares

$92,941
0.0% of portfolio

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $4.97M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account